Navigation Links
MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.

WARREN, N.J., Jan. 18, 2011 /PRNewswire/ -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, filed an amended patent infringement and false marking lawsuit today against BioDelivery Sciences International, Inc. (NASDAQ: BDSI; "BDSI"), MEDA Pharmaceuticals Inc. ("MEDA"), and Aveva Drug Delivery Systems, Inc. ("Aveva") in the United States District Court for the District of New Jersey.

MonoSol Rx's complaint asserts that BDSI, MEDA, and Aveva's manufacture, marketing, and sale of the Onsolis™ film products infringe MonoSol Rx's United States Patent No. 7,824,588 related to methods of making drug-containing films.  As one of the leaders in the development and commercialization of film pharmaceutical and over-the-counter drug products, MonoSol Rx has an extensive technology patent portfolio.

MonoSol Rx filed its patent infringement claim against these defendants initially in November, 2010.  Today's amended complaint adds an additional false marking claim with respect to U.S. Patent No. 5,800,832.

MonoSol Rx is represented in the action by Howrey LLP.

About MonoSol Rx MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in films. PharmFilm® is designed to benefit patients by improving the convenience, efficacy, and compliance of new and currently marketed drugs. The Company's leadership in film drug delivery is supported by strong intellectual property, a portfolio of commercialized prescription and over-the-counter (OTC) drug products, a pipeline of prescription formulations based on PharmFilm® technology, and two recent FDA approvals - Zuplenz®, the first approved prescription oral soluble film for the prevention of chemotherapy-induced, radiotherapy-induced, and postoperative nausea and vomiting, and Suboxone®  sublingual film, the first sublingual film product for the treatment of opioid dependence.  

MonoSol Rx's commercialization strategy for all PharmFilm® products is to partner with the innovator or other specialty pharma companies that can sell-in and manage product sales and marketing.  PharmFilm® is also a tool to help sales and marketing partners differentiate in competitive markets while offering unique advantages over drugs dosed by traditional tablets, capsules and orally disintegrating tablets (ODTs).For existing and future partners, PharmFilm® formulations can also represent revenue-life cycle extensions for products with patent lives that have expired or are approaching expiration.
For press releases and other company information visit Contacts:MonoSol RxKeith Kendall, Executive Vice President(732) 564-5000The Ruth Group
(on behalf of MonoSol Rx)Jason Rando (media)Tel: +1 (646)  Sara Pellegrino (investors)Tel: +1 (646)  

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films
2. MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development
3. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
4. ThermoGenesis Corp. Files Shelf Registration Statement on Form S-3
5. HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication
6. Cannabis Science Files Preliminary 14c Information Statement, the Action is to Create a New Class of Common Stock and Issue Dividend
7. COPAN Files New Patents Following the Development of High Nucleic Acid Yield Flocked Swabs
8. Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma
9. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
10. ERT Files Shelf Registration Statement
11. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015  PTS Diagnostics, the U.S.-based manufacturer ... analyzers, A1CNow ® systems, and PTS Detect™ ... of patents that will propel the company into the ... Europe . The technology is a ... those on smartphones and tablets, and uses test strip ...
(Date:11/30/2015)... , Nov. 30, 2015 Oramed Pharmaceuticals ... focused on the development of oral drug delivery systems, ... agreements valued at up to $50,000,000 with Hefei Tianhui Incubator of Technologies ... oral insulin capsule, ORMD-0801, in China ... Macau . The agreements were signed at ...
(Date:11/30/2015)... , Nov. 30, 2015 Cumberland Pharmaceuticals (CPIX), today ... live at on December 3, 2015. TIME: ... TIME: 3:15p.m. ET LINK: --> ... --> ... where investors are invited to ask the company questions in ...
Breaking Medicine Technology:
(Date:11/30/2015)... Atlanta (PRWEB) , ... November 30, 2015 , ... Using ... detection of prediabetes in American children and adults, according to a new study by ... Improving Detection of Prediabetes in Children and Adults: Using Combinations of Blood Glucose Tests ...
(Date:11/30/2015)... ... ... Newly reviewed and approved “NJ Top Dentist”, Paul Dionne, ... both advanced training and considerable experience in reconstructive dentistry with attention to occlusal ... He is an active Spear Education member providing full mouth restorative and ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology consultations ... and KingMed Diagnostics researchers. Their review of more than 1,500 ... UPMC pathologists resulted in significantly altered treatment plans for more than half of ...
(Date:11/30/2015)... New York, NY (PRWEB) , ... November 30, 2015 , ... ... New York Times,” will be released on December 1, 2015, to coincide with World ... book about the groundbreaking journalist who covered the AIDS epidemic as he was dying ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... promoting breast and prostate cancer education and prevention—is joining forces with the award-winning ... philanthropy and Hollywood elegance on December 7, 2015 at the Union League of ...
Breaking Medicine News(10 mins):